Soldier Health. World Health.
The US Military’s HIV Research Program (MHRP) is at the forefront of the battle against HIV to protect
US troops and reduce the global impact of the disease.
A large-scale HIV vaccine study currently underway is based on the landmark Army-led RV144 “Thai study,” the first vaccine trial to show efficacy.
Learn MoreOur novel acute cohort study provides insights into critical moments of HIV infection in in hopes of finding the keys to long-term HIV remission.
Learn MoreThe Joint West Africa Research Group is leveraging existing platforms and relationships to counter emerging infections in the region.
Read MoreThe US Military’s HIV Research Program (MHRP) is at the forefront of the battle against HIV to protect
US troops and reduce the global impact of the disease.
MHRP researchers and Thai collaborators are leading the way in acute infection studies. One study, called RV254/SEARCH 010 is providing knowledge about the earliest HIV events that may provide clues to developing an effective HIV vaccine or even help identify ways to achieve a functional cure. MHRP spoke with people living with HIV in Thailand about the impact a potential cure would have on their lives.
© 2019 U.S. Military HIV Research Program, Terms of Use & Disclaimer